28
Participants
Start Date
December 12, 2023
Primary Completion Date
September 1, 2025
Study Completion Date
December 1, 2025
BRS201
Groups 1, 2, 3, and 4 will all contain 7 subjects each, with each subject receiving active study drug and placebo in a randomized order; half will receive the placebo first for four weeks followed by active treatment for four weeks, while the other half will receive active treatment for four weeks followed by placebo for four weeks.
Placebo
Groups 1, 2, 3, and 4 will all contain 7 subjects each, with each subject receiving active study drug and placebo in a randomized order; half will receive the placebo first for four weeks followed by active treatment for four weeks, while the other half will receive active treatment for four weeks followed by placebo for four weeks.
RECRUITING
Brigham and Women's Hospital, Chestnut Hill
Brigham and Women's Hospital
OTHER